Revvity Inc.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 28, 2025 · FY), Revvity Inc. reported net income of $241.2M (-10.8% year on year).
| Line item | Dec 28, 2025 · FY | Dec 29, 2024 · FY | Dec 31, 2023 · FY | Jan 1, 2023 · FY |
|---|---|---|---|---|
| Segment revenue | $2.9B | $2.8B | $2.8B | $3.3B |
| Cost of Product and Service Sold | $1.3B | $1.2B | $1.2B | $1.3B |
| Segment selling, general and administrative expenses | $991.9M | $994.1M | $1.0B | $1.0B |
| Segment research and development expenses | $215.8M | $196.8M | $216.6M | $221.6M |
| Operating income from continuing operations | $356.6M | $346.7M | $300.6M | $742.7M |
| Interest and other expense, net | $88.4M | $30.6M | $117.6M | $90.9M |
| Income from continuing operations before income taxes | $268.3M | $316.1M | $183.0M | $651.8M |
| Provision for income taxes | $28.4M | $33.1M | $3.5M | $139.2M |
| Income from continuing operations | $239.9M | $283.1M | $179.5M | $512.7M |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $1.3M | ($12.7M) | — | — |
| Net income | $241.2M | $270.4M | $693.1M | $569.2M |
| Income from continuing operations | $2.06 | $2.31 | $1.44 | $4.06 |
| Income from discontinued operations and dispositions | $0.01 | ($0.1) | $513.6M | $56.5M |
| Net income | $2.07 | $2.21 | $5.56 | $4.51 |
| Line item | Jul 5, 2026 · Q2 | Apr 5, 2026 · Q1 | Sep 28, 2025 · Q3 | Jun 29, 2025 · Q2 |
|---|---|---|---|---|
| Segment revenue | $729.7M | $711.1M | $698.9M | $720.3M |
| Cost of Product and Service Sold | $312.8M | $323.5M | $324.3M | $327.7M |
| Selling, general and administrative expenses | $278.6M | $253.9M | $241.9M | $248.5M |
| Research and development expenses | $49.0M | $57.9M | $50.8M | $53.3M |
| Operating income from continuing operations | $89.3M | $75.9M | $81.9M | $90.8M |
| Interest And Other Expense Net | $25.8M | $25.9M | $26.2M | $22.1M |
| Income from continuing operations before income taxes | $63.5M | $50.0M | $55.7M | $68.7M |
| Provision for income taxes | $10.1M | $9.1M | $8.5M | $13.4M |
| Income from continuing operations | $53.5M | $40.9M | $47.2M | $55.2M |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | ($1.7M) | ($175.0K) | ($569.0K) | ($1.3M) |
| Net income | $51.8M | $40.7M | $46.7M | $53.9M |
| Income (loss) from continuing operations (per share) | $0.48 | $0.37 | $0.41 | $0.47 |
| Gain (loss) on discontinued operations and dispositions (per share) | -$0.01 | $0.00 | -$0.01 | -$0.01 |
| Net income (per share) | $0.47 | $0.36 | $0.40 | $0.46 |
| Basic (in shares) | 111.6M | 111.9M | 115.4M | 117.5M |
| Diluted (in shares) | 111.6M | 111.9M | 115.5M | 117.5M |
| Line item | Dec 28, 2025 · FY | Dec 29, 2024 · FY | Dec 31, 2023 · FY | Jan 1, 2023 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $919.9M | $1.2B | $913.2M | $454.4M |
| Accounts receivable, net | $744.7M | $632.4M | $632.8M | $612.8M |
| Inventories | $379.5M | $367.6M | $428.1M | $405.5M |
| Other current assets | $195.7M | $186.2M | $337.1M | $122.3M |
| Total current assets | $2.2B | $2.3B | $3.0B | $3.3B |
| Property, plant and equipment, net | $479.2M | $482.2M | $509.7M | $482.9M |
| Operating Lease, Right-of-Use Asset | $165.4M | $167.7M | $155.1M | $188.4M |
| Intangible assets, net | $2.3B | $2.6B | $3.0B | $3.4B |
| Beginning balance | $6.6B | $6.5B | $6.5B | $6.5B |
| Other assets, net | $323.5M | $288.4M | $343.0M | $311.1M |
| Total assets | $12.2B | $12.4B | $13.6B | $14.1B |
| Current portion of long-term debt | $588.8M | $242.0K | $721.9M | $470.9M |
| Accounts payable | $185.5M | $167.5M | $204.1M | $272.8M |
| Accrued expenses and other current liabilities | $557.0M | $485.4M | $524.5M | $527.9M |
| Total current liabilities | $1.3B | $653.1M | $1.5B | $1.5B |
| Long-term debt | $2.6B | $3.2B | $3.2B | $3.9B |
| Long-term liabilities | $807.5M | $770.5M | $930.9M | $1.1B |
| Operating Lease, Liability, Noncurrent | $148.1M | $151.5M | $132.7M | $170.0M |
| Total liabilities | $4.9B | $4.7B | $5.7B | $6.7B |
| Preferred stock—$1 par value per share, authorized 1,000,000 shares; none issued or outstanding | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock—$1 par value per share, authorized 300,000,000 shares; issued and outstanding 112,281,000 and 120,646,000 shares at December 28, 2025 and December 29, 2024, respectively | $112281000.00 | $120646000.00 | $123426000.00 | $126300000.00 |
| Capital in excess of par value | $1.3B | $2.1B | $2.4B | $2.8B |
| Retained earnings | $6.1B | $5.8B | $5.6B | $5.0B |
| Accumulated other comprehensive loss | ($222.1M) | ($396.1M) | ($276.7M) | ($447.5M) |
| Total stockholders' equity | $7.3B | $7.7B | $7.9B | $7.4B |
| Total liabilities and stockholders' equity | $12.2B | $12.4B | $13.6B | $14.1B |
| Line item | Jul 5, 2026 | Apr 5, 2026 | Sep 28, 2025 | Jun 29, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $1.0B | $860.3M | $931.4M | $991.8M |
| Accounts receivable, net | $709.2M | $691.4M | $680.3M | $661.1M |
| Inventories, net | $378.5M | $387.5M | $379.9M | $388.5M |
| Other current assets | $187.1M | $189.1M | $152.2M | $194.7M |
| Total current assets | $2.3B | $2.1B | $2.1B | $2.2B |
| Property, plant and equipment, net | $456.3M | $465.6M | $497.1M | $499.0M |
| Operating Lease, Right-of-Use Asset | $150.9M | $163.3M | $171.1M | $177.2M |
| Intangible assets, net | $2.2B | $2.3B | $2.4B | $2.5B |
| Goodwill | $6.6B | $6.6B | $6.6B | $6.6B |
| Other assets, net | $309.1M | $322.1M | $300.4M | $321.1M |
| Total assets | $12.0B | $12.0B | $12.1B | $12.4B |
| Current portion of long-term debt | $572.2M | $575.8M | $583.8M | $230.0K |
| Accounts payable | $165.7M | $169.7M | $175.8M | $178.2M |
| Accrued expenses and other current liabilities | $538.5M | $493.1M | $463.1M | $493.4M |
| Total current liabilities | $1.3B | $1.2B | $1.2B | $671.8M |
| Long-term debt | $2.6B | $2.6B | $2.6B | $3.2B |
| Deferred taxes and other long-term liabilities | $771.4M | $800.9M | $755.2M | $760.2M |
| Operating Lease, Liability, Noncurrent | $136.3M | $142.3M | $154.5M | $160.3M |
| Total liabilities | $4.8B | $4.8B | $4.8B | $4.8B |
| Preferred stock—$1 par value per share, authorized 1,000,000 shares; none issued or outstanding | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock—$1 par value per share, authorized 300,000,000 shares; issued and outstanding 111,584,000 shares and 112,281,000 shares at July 5, 2026 and December 28, 2025, respectively | $111584000.00 | $111629000.00 | $114030000.00 | $116331000.00 |
| Capital in excess of par value | $1.2B | $1.2B | $1.5B | $1.7B |
| Retained earnings | $6.1B | $6.1B | $6.0B | $5.9B |
| Accumulated other comprehensive loss | ($256.6M) | ($253.6M) | ($179.8M) | ($157.5M) |
| Total stockholders’ equity | $7.2B | $7.2B | $7.4B | $7.6B |
| Total liabilities and stockholders’ equity | $12.0B | $12.0B | $12.1B | $12.4B |
| Line item | Dec 28, 2025 · FY | Dec 29, 2024 · FY | Dec 31, 2023 · FY | Jan 1, 2023 · FY |
|---|---|---|---|---|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $921.0M | $1.2B | $914.4M | $470.7M |
| Net income | $241.2M | $270.4M | $693.1M | $569.2M |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | ($1.3M) | $12.7M | — | — |
| Income from continuing operations | $239.9M | $283.1M | $179.5M | $512.7M |
| Restructuring Charges and Changes in Estimates | $55.9M | $17.5M | — | — |
| Depreciation and amortization | $405.3M | $427.8M | $431.8M | $427.0M |
| Stock-based compensation | $22.8M | $37.8M | $41.4M | $51.5M |
| Pension and other post-retirement expense | $3.6M | $9.4M | $23.1M | ($23.1M) |
| Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) | ($1.4M) | ($1.9M) | $4.2M | ($1.4M) |
| Deferred taxes | ($61.5M) | ($102.2M) | ($123.7M) | ($105.9M) |
| Contingencies and Non-Cash Tax Matters | ($86.0K) | ($8.1M) | $26.2M | ($1.5M) |
| Amortization of deferred debt issuance costs, interest rate hedge and accretion of discounts | $4.6M | $6.1M | $7.3M | $7.3M |
| Asset Impairment Charges | $4.8M | $22.8M | $0 | $0 |
| Change in fair value of investments | $11.5M | ($8.0M) | — | — |
| Gain (Loss) on Extinguishment of Debt | $0 | $0 | — | ($2.9M) |
| Unrealized Gain (Loss), Foreign Currency Transaction, before Tax | $273.0K | ($1.1M) | — | — |
| Accounts receivable, net | ($101.0M) | ($16.0M) | ($9.0M) | $66.1M |
| Inventories, net | $14.8M | $45.1M | ($14.1M) | ($48.6M) |
| Accounts payable | $7.3M | ($26.0M) | ($76.4M) | ($43.8M) |
| Accrued expenses and other | ($17.9M) | ($21.4M) | ($291.8M) | ($236.6M) |
| Net cash provided by operating activities of continuing operations | $589.0M | $665.0M | $279.4M | $672.5M |
| Net cash used in operating activities of discontinued operations | ($6.0M) | ($36.7M) | ($188.1M) | $7.3M |
| Net cash provided by operating activities | $582.9M | $628.3M | $91.3M | $679.8M |
| Capital expenditures | ($73.5M) | ($86.6M) | ($81.4M) | ($85.6M) |
| Purchases of investments and notes receivables | ($385.0K) | ($6.6M) | — | — |
| Payments to Acquire Marketable Securities | $0 | $0 | — | — |
| Proceeds from Sale and Maturity of Marketable Securities | $0 | $710.0M | — | — |
| Proceeds from Divestiture of Businesses | $304.0K | $0 | $153.0K | $14.5M |
| Cash paid for acquisitions, net of cash acquired | $0 | $0 | ($2.1M) | ($7.5M) |
| Net cash (used in) provided by investing activities of continuing operations | ($73.6M) | $619.3M | ($761.2M) | ($116.9M) |
| Net cash provided by investing activities of discontinued operations | $56.3M | $156.9M | $2.1B | ($15.9M) |
| Net cash (used in) provided by investing activities | ($17.4M) | $776.2M | $1.3B | ($132.9M) |
| Payments of Senior Debt | $0 | ($711.5M) | ($523.8M) | ($57.9M) |
| Payments of debt financing and equity issuance costs | ($2.5M) | $0 | ($15.0K) | $0 |
| Proceeds from (Repayments of) Other Debt | ($521.0K) | ($11.6M) | $6.3M | ($1.3M) |
| Payments for acquisition-related contingent consideration | ($3.8M) | ($8.8M) | ($10.1M) | ($5.0K) |
| Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | 2.9M | 7.7M | 4.3M | 14.1M |
| Purchases of common stock | ($820.8M) | ($369.6M) | ($388.9M) | ($80.6M) |
| Dividends paid | ($32.8M) | ($34.5M) | ($35.0M) | ($35.3M) |
| Net cash (used in) provided by financing activities | ($857.5M) | ($1.1B) | ($947.1M) | ($661.8M) |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $48.5M | ($26.1M) | ($14.0M) | ($33.7M) |
| Net (decrease) increase in cash, cash equivalents and restricted cash | ($243.4M) | $250.1M | $443.6M | ($148.6M) |
| Cash and cash equivalents at beginning of year | $1.2B | $913.2M | $454.4M | $603.3M |
| Restricted Cash, Current | $6.0K | $1.1M | $1.2M | $1.0M |
| Restricted Cash, Noncurrent | $1.2M | $0 | $0 | $349.0K |
| Line item | Jul 5, 2026 · YTD | Apr 5, 2026 · Q1 | Sep 28, 2025 · YTD | Jun 29, 2025 · YTD |
|---|---|---|---|---|
| Net income | $92.5M | $40.7M | $142.8M | $96.2M |
| Loss from discontinued operations, net of income taxes | $1.8M | $175.0K | $1.3M | $706.0K |
| Income from continuing operations | $94.4M | $40.9M | $144.1M | $96.9M |
| Restructuring and other costs | $46.2M | $10.7M | — | — |
| Depreciation and amortization | $207.1M | $105.1M | $302.3M | $200.2M |
| Gain on disposition of businesses and assets, net | ($5.1M) | ($5.1M) | — | — |
| Stock-based compensation | $19.4M | $8.7M | $26.9M | $17.9M |
| Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) | $1.5M | ($99.0K) | ($59.0K) | ($166.0K) |
| Amortization of deferred debt financing costs and accretion of discounts | $2.4M | $1.1M | $3.6M | $2.3M |
| Change in fair value of financial securities | $9.5M | $4.2M | $3.5M | ($1.1M) |
| Unrealized Foreign Exchange (Gain) Loss Related to Proceed from Sale of Business | $186.0K | $100.0K | $222.0K | $140.0K |
| Accounts receivable, net | $43.9M | $61.5M | ($41.6M) | ($21.9M) |
| Inventories | ($4.8M) | ($12.8M) | $12.5M | $5.6M |
| Accounts payable | ($18.1M) | ($13.7M) | $270.0K | $3.3M |
| Increase (Decrease) in Accrued Expenses and Other | ($78.9M) | ($74.7M) | ($69.0M) | ($49.2M) |
| Net cash provided by operating activities of continuing operations | $317.8M | $125.9M | $407.0M | $268.4M |
| Net cash used in operating activities of discontinued operations | ($10.7M) | ($10.7M) | ($6.0M) | ($5.9M) |
| Net cash provided by operating activities | $307.2M | $115.2M | $401.0M | $262.5M |
| Capital expenditures | ($30.8M) | ($19.8M) | ($53.4M) | ($34.9M) |
| Purchases of investments and notes receivables | ($3.6M) | ($1.1M) | ($29.0K) | $0 |
| Proceeds from investments and notes receivables | $7.5M | $677.0K | $0 | — |
| Proceeds from disposition of property, plant and equipment | $12.0M | $9.0M | — | — |
| Proceeds from disposition of businesses and assets | $158.0K | $158.0K | $229.0K | $229.0K |
| Cash paid for acquisitions, net of cash acquired | ($67.1M) | ($67.3M) | — | — |
| Net cash used in investing activities of continuing operations | ($81.8M) | ($78.3M) | ($53.2M) | ($34.6M) |
| Net cash provided by investing activities of discontinued operations | $0 | $0 | $56.3M | $18.8M |
| Net cash used in investing activities | ($81.8M) | ($78.3M) | $3.1M | ($15.9M) |
| Payments of debt financing issuance costs | $0 | $0 | ($2.5M) | ($2.5M) |
| Payments of other credit facilities | $0 | $0 | ($158.0K) | ($103.0K) |
| Payment for Contingent Consideration Liability, Financing Activities | ($350.0K) | $0 | ($3.8M) | ($2.0M) |
| Proceeds from issuance of common stock under stock plans | $6.4M | $5.4M | $2.6M | $2.6M |
| Purchases of common stock | ($102.5M) | ($86.5M) | ($652.5M) | ($447.5M) |
| Dividends paid | ($15.7M) | ($7.8M) | ($24.8M) | ($16.7M) |
| Net cash used in financing activities | ($112.1M) | ($88.9M) | ($681.2M) | ($466.1M) |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | ($10.2M) | ($7.6M) | $45.3M | $48.1M |
| Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalent | $103.2M | ($59.6M) | ($231.9M) | ($171.5M) |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at beginning of period | $921.0M | $921.0M | $1.2B | $1.2B |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at end of period | $1.0B | $861.5M | $932.6M | $993.0M |
| Cash and cash equivalents | $1.0B | $860.3M | $931.4M | $991.8M |
| Restricted Cash, Current | $713.0K | $428.0K | $1.2M | $1.1M |
| Restricted Cash, Noncurrent | $525.0K | $718.0K | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $1.0B | $861.5M | $932.6M | $993.0M |
Revvity Inc. score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.